Interest in advancing research in stroke therapeutics has historically come in fits and starts. Now with intravenous tPA and thrombectomy in regular use, experts are looking to get a step ahead of the damage.
The child neurology resident at NYU Langone spoke about ways for residents to identify and address impaired colleagues that suffer from depression and burnout.
Recommendations to health care professionals in the community who play a role in managing pediatric patients with multiple sclerosis and considerations for improving how the condition is managed.
An overview of therapies under investigation in pediatric multiple sclerosis.
Drs Brenda L. Banwell and Lauren B. Krupp highlight current unmet needs regarding the treatment and management of patients with pediatric onset multiple sclerosis.
Experts who treat patients with multiple sclerosis react to the availability of oral fingolimod for pediatric patients and highlight considerations for utilizing the therapy in practice.
An overview of fingolimod for patients with relapsing pediatric multiple sclerosis based on the PARADIGMS trial and the FDA’s breakthrough therapy designation of the oral therapy for appropriate patients.
Drs Brenda L. Banwell and Lauren B. Krupp review the design and outcomes of the PARADIGMS trial with fingolimod in pediatric patients with multiple sclerosis.